Guided Therapeutics Program (GTx)

GTx is developing new image-guided technologies for advanced therapeutics in surgery, interventional radiology and radiation medicine.
Overview

Established in 2006, the Guided Therapeutics Program (GTx) at the University Health Network is a collaboration of surgeons, medical imaging specialists, radiation oncologists, interventional radiologists, physicists, nanotechnology engineers and biomedical engineers all focused on the research, development and clinical implementation of innovative technologies to enable novel cancer diagnostics and therapeutics. The current scope of the program includes research and development in pre-clinical and translational/clinical settings. 

The GTx program has coordinated the planning and implementation of image-guided resources across UHN. This includes the GTx-Lab with 1 fully equipped operating room, the GTx-OR and GTx-MR suite at the Toronto General Hospital/UHN.

The facility is led by:

Unique Capacities
  • Unique multi-disciplinary research collaboration among scientists, engineers and clinicians with a shared vision toward revolutionary cancer interventions
  • High-precision, image-guided interventions (including surgery, radiotherapy and cell-based therapies)
Available Equipment
  • Operating room
    • GTx-Lab: basic research and development of guidance technologies; preclinical models testing; preclinical Cone-Beam CT imaging
    • GTx-OR: translational research image-guided OR, focusing on head and neck, chest and breast procedures with dual energy CT scanner and robotically controlled Cone-beam CT and fluoroscopy imaging
    • MRI-Interventional Suite: translational research image-guided OR, focusing on prostate and advanced applications of HIFU with 1.5T MRI
  • Image-guidance technologies
    MRI, CT, cone-beam CT, ultrasound, optical fluorescence, HIFU, real-time tracking and navigation, deformable image registration.
Services

Research, development and translation of advanced imaging and guidance technologies in therapeutic interventions, including surgery, radiation therapy and interventional radiology.
Primary focus is on cancer interventions. Mandate is toward creation and translation of new technologies and therapeutic techniques, with a strong emphasis on research. 

Using the Facility
Resources are available on a collaborative basis. Research collaborations with physicists, engineers, surgeon scientists, radiation oncologists and other UHN investigators are welcome.

Sample Preparation
Please contact Dr. Robert Weersink (robert.weersink@rmp.uhn.on.ca, 416-946-4501 ) for more information.
Contacts

Dr. Robert Weersink
416-946-4501 (16-5740)
Princess Margaret Cancer Research Tower
110 College St, Room 7-1001
Toronto, Ontario, M5G 2C4

Comments

Add new comment

GTx is developing new image-guided technologies for advanced therapeutics in surgery, interventional radiology and radiation medicine.
Overview

Established in 2006, the Guided Therapeutics Program (GTx) at the University Health Network is a collaboration of surgeons, medical imaging specialists, radiation oncologists, interventional radiologists, physicists, nanotechnology engineers and biomedical engineers all focused on the research, development and clinical implementation of innovative technologies to enable novel cancer diagnostics and therapeutics. The current scope of the program includes research and development in pre-clinical and translational/clinical settings. 

The GTx program has coordinated the planning and implementation of image-guided resources across UHN. This includes the GTx-Lab with 1 fully equipped operating room, the GTx-OR and GTx-MR suite at the Toronto General Hospital/UHN.

The facility is led by:

Unique Capacities
  • Unique multi-disciplinary research collaboration among scientists, engineers and clinicians with a shared vision toward revolutionary cancer interventions
  • High-precision, image-guided interventions (including surgery, radiotherapy and cell-based therapies)
Available Equipment
  • Operating room
    • GTx-Lab: basic research and development of guidance technologies; preclinical models testing; preclinical Cone-Beam CT imaging
    • GTx-OR: translational research image-guided OR, focusing on head and neck, chest and breast procedures with dual energy CT scanner and robotically controlled Cone-beam CT and fluoroscopy imaging
    • MRI-Interventional Suite: translational research image-guided OR, focusing on prostate and advanced applications of HIFU with 1.5T MRI
  • Image-guidance technologies
    MRI, CT, cone-beam CT, ultrasound, optical fluorescence, HIFU, real-time tracking and navigation, deformable image registration.
Services

Research, development and translation of advanced imaging and guidance technologies in therapeutic interventions, including surgery, radiation therapy and interventional radiology.
Primary focus is on cancer interventions. Mandate is toward creation and translation of new technologies and therapeutic techniques, with a strong emphasis on research. 

Using the Facility
Resources are available on a collaborative basis. Research collaborations with physicists, engineers, surgeon scientists, radiation oncologists and other UHN investigators are welcome.

Sample Preparation
Please contact Dr. Robert Weersink (robert.weersink@rmp.uhn.on.ca, 416-946-4501 ) for more information.
Contacts

Dr. Robert Weersink
416-946-4501 (16-5740)
Princess Margaret Cancer Research Tower
110 College St, Room 7-1001
Toronto, Ontario, M5G 2C4